NCT02268058

Brief Summary

Concussions and headache are a significant problem for children and athletes. While headache generally resolves within 7-10 days; a significant proportion of children, 72-93% experience prolonged headache as a symptom of Post Concussion Syndrome (PCS). The prevailing clinical view is that mild head injuries resolve with little chance of complications. However, the reality is quite different. Concussion in children presents with a range of severity and results in both short and long-term physical, cognitive, emotional and behavioural sequelae known as PCS with varying times to resolution. To date there are no specific treatments for headache pain related to concussion. Physical and cognitive rest is the mainstay of initial concussion management. The number of children presenting to ED's with a history of concussion and headache is increasing. Presently there are no evidence based guidelines available to guide the medical team to effectively and consistently manage their headache. Our present standard of care is based on the CANCHILD concussion guidelines outlining the child's return to school and activity. Yet, our present standard of treatment is compromised and somewhat counterproductive if we are not treating the child's headache pain. Our pilot study ' An Open Label Randomized Control Pilot Study Examining Treatment of Headache In The Post-Concussive Youth' showed that routine administration of oral analgesia improves the child's headache symptoms and helps with school re-entry one week post injury, compared to a standard care group defined as non routine administration of pain medications.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2013

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 9, 2014

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 20, 2014

Completed
2 years until next milestone

Results Posted

Study results publicly available

October 20, 2016

Completed
Last Updated

October 20, 2016

Status Verified

October 1, 2016

Enrollment Period

6 months

First QC Date

October 9, 2014

Results QC Date

October 18, 2016

Last Update Submit

October 19, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Headache Days

    study participants completed a one week diary at home stating if they had headaches.

    one week

Secondary Outcomes (1)

  • Percentage of Study Participants That Returned to School at One Week Post Concussion

    one week

Other Outcomes (2)

  • Headache Intensity Per Day for One Week

    one week

  • Number of Headaches a Day

    one week

Study Arms (4)

tx 1: acetaminophen and education

ACTIVE COMPARATOR

Patient took routinely acetaminophen every 4 hours when awake for a 72 hour period and documented their headaches for a week. Patient and family received standard education on concussion management in the Emergency department.

Drug: Acetaminophen

Tx 2: ibuprofen and education

ACTIVE COMPARATOR

Patient took routinely ibuprofen every 6 hours when awake for a 72 hour period and documented their headaches for a week. Patient and family received standard education on concussion management in the Emergency department.

Drug: Ibuprofen

Tx 3: ibuprofen/acetaminophen/education

ACTIVE COMPARATOR

Patient took routinely ibuprofen (Q6H) and acetaminophen (Q4H) for when awake for 72 hours post concussion and documented their headaches for a week. Patient and family received standard education on concussion management in the Emergency Department.

Drug: AcetaminophenDrug: Ibuprofen

Tx 4: no routine meds and education

NO INTERVENTION

Patient was advised to manage headaches as they typically would. There was no instruction given for the routine administration of either ibuprofen or acetaminophen. The Patient and family received standard education in the ER department and diarized their headaches and medications they took for a one week period.

Interventions

routine administration of medication for a 72 hour period

Also known as: tylenol
Tx 3: ibuprofen/acetaminophen/educationtx 1: acetaminophen and education

routine administration of medication for a 72 hour period

Also known as: advil
Tx 2: ibuprofen and educationTx 3: ibuprofen/acetaminophen/education

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • diagnosed with a first time concussion
  • english speaking
  • presenting to Emergency with headache 24-48 hours post concussion
  • normal Glascow Coma Scale
  • years of age

You may not qualify if:

  • postive findings on CT scan
  • patient with cervical injury
  • history of multiple concussions
  • positive neurology

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Brain ConcussionHeadache

Interventions

AcetaminophenIbuprofen

Condition Hierarchy (Ancestors)

Brain Injuries, TraumaticBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemHead Injuries, ClosedWounds and InjuriesWounds, NonpenetratingPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesPhenylpropionatesAcids, CarbocyclicCarboxylic Acids

Limitations and Caveats

open label study, not blinded pilot study, no sample size calculation

Results Point of Contact

Title
Dr. Tina Petrelli
Organization
McMaster Children's Hospital

Study Officials

  • Tina m Petrelli, PhD

    McMaster Children's Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
McMaster Children's Hospital

Study Record Dates

First Submitted

October 9, 2014

First Posted

October 20, 2014

Study Start

October 1, 2013

Primary Completion

April 1, 2014

Study Completion

May 1, 2014

Last Updated

October 20, 2016

Results First Posted

October 20, 2016

Record last verified: 2016-10